SCHEMBL4583679

SCHEMBL4583679

CC(C)(C)OC(=O)NC[CH]Cc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.53
CA12 O43570 1/20 0.49
CA1 P00915 1/20 0.49
CA7 P43166 1/20 0.49
CA14 Q9ULX7 1/20 0.49
SYK P43405 1/20 0.48
AKT1 P31749 2/20 0.47
CTSS P25774 5/20 0.46
CTSK P43235 3/20 0.46
CTSL P07711 2/20 0.46
CTSB P07858 2/20 0.46
PPARA Q07869 2/20 0.45
PPARG P37231 1/20 0.45
ATM Q13315 1/20 0.45
SIGMAR1 Q99720 2/20 0.44
NAMPT P43490 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
KDM4A O75164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8620846 0.80 HDAC1 (0.42) IDO1CA1NAMPTKDM4A
SCHEMBL23959499 0.79 EPHX2 (0.49) IDO1CA12CA1CA7CA14
SCHEMBL7354883 0.79 KCNA5 (0.43) IDO1CA12CA1CA7CA14
SCHEMBL3838871 0.79 CA12 (0.63) IDO1CA12CA1CA7CA14
SCHEMBL5041887 0.78 CA12 (0.51) IDO1CA12CA1CA7CA14
SCHEMBL7453149 0.78 NFKB1 (0.46) IDO1CA12CA1CA7CA14
SCHEMBL2404127 0.78 TDP1 (0.50) CA12CA1CA7CA14CTSK
SCHEMBL6243241 0.78 SYK (0.54) IDO1CA12CA1CA7CA14
SCHEMBL7062155 0.77 IDO1 (0.49) IDO1CA12CA1CA7CA14
Acetaldehyde SCHEMBL3344850 0.77 CA12 (0.57) IDO1CA12CA1CA7CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5801183-A HETEROCYCLC ALCOHOLS FOR NERVOUS SYSTEM DISORDERS STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON (US) 1998-09-01 US claimed
EP-1968568-A2 INHIBITORS OF Akt ACTIVITY SmithKline Beecham Corporation (US) 2008-09-17 EP disclosed
WO-2007076423-A2 INHIBITORS OF Akt ACTIVITY SMITHKLINE BEECHAM CORPORATION (US) 2007-07-05 WO disclosed
US-5801183-A HETEROCYCLC ALCOHOLS FOR NERVOUS SYSTEM DISORDERS STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON (US) 1998-09-01 US disclosed
EP-0805809-A2 AZA AND AZA (N-OXY) ANALOGS OF GLYCINE/NMDA RECEPTOR ANTAGONISTS State of Oregon through Oregon State Board of Higher Education for and on behalf of Oregon Health Sc. Univ. & Univ. of Oregon (US) 1997-11-12 EP disclosed
WO-1996022990-A2 AZA AND AZA (N-OXY) ANALOGS OF GLYCINE/NMDA RECEPTOR ANTAGONISTS STATE OF OREGON, acting by and through THE OREGON STATE BOARD OF HIGHER EDUCATION, acting for and onbehalf of THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON, EUGENE, OREGON (US) 1996-08-01 WO disclosed
US-5475008-A Selective non-competitive antagonists of n-methyl-d-aspartate receptors MERCK SHARP & DOHME LIMITED (GB) 1995-12-12 US disclosed
EP-0459561-B1 Dioxo-tetrahydroquinoline derivatives MERCK SHARP & DOHME (GB) 1995-09-20 EP disclosed
EP-0614363-A1 QUINOLONE DERIVATIVES MERCK SHARP & DOHME LTD. (GB) 1994-09-14 EP disclosed
US-5268378-A Oxo group in 2 and 4 position MERCK SHARP & DOHME, LIMITED (GB) 1993-12-07 US disclosed
WO-1993010783-A2 QUINOLONE DERIVATIVES AND THEIR USE AS AMPA AND NMDA RECEPTOR ANTAGONISTS MERCK SHARP & DOHME LIMITED (GB) 1993-06-10 WO disclosed
EP-0459561-A2 Dioxo-tetrahydroquinoline derivatives MERCK SHARP & DOHME LTD. (GB) 1991-12-04 EP disclosed